NCT07197034Phase 3Terminated

The Hunger Elimination or Reduction Objective (HERO ) Open -Label Extension (OLE) Trial

Study sponsor: Aardvark Therapeutics, Inc. · AARD

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-04-15Actual
Enrollment · participants19Actual
Source updated2026-06-30Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 5 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 90 participants (planned). After: 19 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Mar 2027. After: 15 Apr 2026.

Recruitment status changed

Before: Suspended. After: Terminated.

Check registry source

· 1 field changed

Recruitment status changed

Before: Recruiting. After: Suspended.

Check registry source